Skip to main content

MoneyWorks4Me

Colinz Laboratories informs about quarterly statement of investor complaints

10 Jan 2017 Evaluate

Colinz Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.70
Dr. Reddys Labs. 1380.00
Cipla 1408.35
Lupin 2017.55
Zydus Lifesciences 1203.00
View more..